Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q1 FY25 results · Apr–Jun 2024
Acutaas Chemicals reported revenue from operations of ₹176.67 crore (up 24.1% from Q1 FY24) and net profit of ₹14.69 crore (down 11.8% from Q1 FY24) for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 176.67 | 142.35 | +24.1% | 224.96 | −21.5% |
| Other income | 1.04 | 1.10 | −5.4% | 1.34 | −22.4% |
| Total income | 177.71 | 143.45 | +23.9% | 226.30 | −21.5% |
| Profit before tax | 19.95 | 22.32 | −10.6% | 37.20 | −46.4% |
| Net profit for the period | 14.69 | 16.65 | −11.8% | 25.68 | −42.8% |
| Attributable to shareholders of the company | 13.95 | — | — | 25.15 | −44.5% |
| EPS, basic (₹) | 3.67 | 4.57 | not comparable | 6.86 | not comparable |
| Net margin (%) | 8.3 | 11.7 | 11.4 |
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 171.14 | 142.35 | +20.2% | 219.94 | −22.2% |
| Other income | 1.90 | 1.10 | +72.1% | 8.55 | −77.8% |
| Total income | 173.03 | 143.45 | +20.6% | 228.49 | −24.3% |
| Profit before tax | 18.20 | 22.53 | −19.2% | 42.29 | −57.0% |
| Net profit for the period | 13.72 | 16.86 | −18.6% | 32.08 | −57.2% |
| EPS, basic (₹) | 3.43 | 4.63 | not comparable | 8.75 | not comparable |
| Net margin (%) | 8.0 | 11.8 | 14.6 |
Consolidated
- Filed with BSE
- 14 Aug 2024, 10:57 IST
- Board meeting
- 12 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 Aug 2024, 10:57 IST
- Board meeting
- 12 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE